Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters











Database
Language
Publication year range
1.
Nat Commun ; 12(1): 3852, 2021 06 22.
Article in English | MEDLINE | ID: mdl-34158500

ABSTRACT

Vertebrate muscles and tendons are derived from distinct embryonic origins yet they must interact in order to facilitate muscle contraction and body movements. How robust muscle tendon junctions (MTJs) form to be able to withstand contraction forces is still not understood. Using techniques at a single cell resolution we reexamine the classical view of distinct identities for the tissues composing the musculoskeletal system. We identify fibroblasts that have switched on a myogenic program and demonstrate these dual identity cells fuse into the developing muscle fibers along the MTJs facilitating the introduction of fibroblast-specific transcripts into the elongating myofibers. We suggest this mechanism resulting in a hybrid muscle fiber, primarily along the fiber tips, enables a smooth transition from muscle fiber characteristics towards tendon features essential for forming robust MTJs. We propose that dual characteristics of junctional cells could be a common mechanism for generating stable interactions between tissues throughout the musculoskeletal system.


Subject(s)
Fibroblasts/metabolism , Intercellular Junctions/metabolism , Muscle Fibers, Skeletal/metabolism , Myofibrils/metabolism , Tendons/metabolism , Animals , Cell Fusion , Cells, Cultured , Fibroblasts/cytology , Gene Expression , Immunohistochemistry/methods , In Situ Hybridization, Fluorescence/methods , Mice, Inbred C57BL , Mice, Transgenic , Muscle Contraction/genetics , Muscle Development/genetics , Muscle Fibers, Skeletal/cytology , Musculoskeletal System/cytology , Musculoskeletal System/metabolism , RNA-Seq/methods , Tendons/cytology
2.
Acta Diabetol ; 57(7): 891-898, 2020 Jul.
Article in English | MEDLINE | ID: mdl-32124075

ABSTRACT

BACKGROUND: Studies by our group demonstrated brain-derived neurotrophic factor (BDNF) levels in blood and BDNF-Val66met-SNP as potential biomarkers in chemotherapy-induced peripheral neuropathy. Here, we evaluate symptoms of peripheral neuropathy (PN) and depression in patients with type II diabetes mellitus in search of an association with serum BDNF levels and the Val66Met-SNP. METHODS: In total, 90 patients enrolled in the study; 23 (25.6%) had known PN, as determined by nerve conduction studies (NCS-PN), and 67 (74.4%) were not diagnosed with PN (U-PN). PN symptoms were assessed and graded in these groups using the total neuropathy score (TNSr) and DN4 scales. Small nerve fiber testing of sensitivity thresholds to cold, warm and hot pain signals was performed using the Q-sense device. Depression was assessed using the PHQ9 questionnaire. BDNF protein levels and Val66Met-SNP were determined with ELISA and Sanger sequencing, respectively. RESULTS: NCS-PN patients showed lower serum BDNF levels alongside significantly higher TNSr, DN4 and PHQ9 scores and lower hot pain sensitivity thresholds as compared to U-PN patients. Patients with Met-BDNF-SNP showed increased TNSr scores and lower hot pain sensitivity thresholds as compared to patients with Val-BDNF-SNP. Depression showed a weaker correlation with sensitivity thresholds to hot pain signals as compared to TNSr and DN4 scores. CONCLUSIONS: Diminished peripheral BDNF resources and Met-BDNF-SNP genotype are associated with augmented symptoms of PN in patients with type II diabetes mellitus. Sensitivity thresholds to hot pain signals may be less influenced by depression and possibly more accurately detect PN symptoms in diabetic patients.


Subject(s)
Brain-Derived Neurotrophic Factor/blood , Brain-Derived Neurotrophic Factor/genetics , Diabetes Mellitus, Type 2/complications , Diabetic Neuropathies/blood , Diabetic Neuropathies/genetics , Polymorphism, Single Nucleotide , Adult , Aged , Amino Acid Substitution , Biomarkers/blood , Case-Control Studies , Diabetes Mellitus, Type 2/blood , Diabetes Mellitus, Type 2/genetics , Female , Genetic Predisposition to Disease , Genotype , Humans , Male , Methionine/genetics , Middle Aged , Peripheral Nervous System Diseases/blood , Peripheral Nervous System Diseases/complications , Peripheral Nervous System Diseases/genetics , Valine/genetics
3.
Dev Cell ; 36(5): 550-61, 2016 Mar 07.
Article in English | MEDLINE | ID: mdl-26954549

ABSTRACT

For muscles to function, myofibers have to stretch and anchor at the myotendinous junction (MTJ), a region rich in extracellular matrix (ECM). Integrin signaling is required for MTJ formation, and mutations affecting the cascade lead to muscular dystrophies in mice and humans. Underlying mechanisms for integrin activation at the MTJ and ECM modifications regulating its signaling are unclear. We show that lysyl oxidase-like 3 (LoxL3) is a key regulator of integrin signaling that ensures localized control of the cascade. In LoxL3 mutants, myofibers anchor prematurely or overshoot to adjacent somites, and are loose and lack tension. We find that LoxL3 complexes with and directly oxidizes Fibronectin (FN), an ECM scaffold protein and integrin ligand enriched at the MTJ. We identify a mechanism whereby localized LoxL3 secretion from myofiber termini oxidizes FN, enabling enhanced integrin activation at the tips of myofibers and ensuring correct positioning and anchoring of myofibers along the MTJ.


Subject(s)
Amino Acid Oxidoreductases/metabolism , Cell Adhesion/physiology , Fibronectins/metabolism , Integrins/metabolism , Muscles/metabolism , Animals , Extracellular Matrix/metabolism , Extracellular Matrix Proteins/metabolism , Mice , Myofibrils/metabolism , Oxidation-Reduction , Somites/metabolism , Tendons/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL